TTNP Titan Pharmaceuticals Inc

For the quarter ended 30/9/2022, Titan Pharmaceuticals Inc's revenues decreased by 36.67% and amounted to 95.00K. Net income decreased by 7.15% to -2.64M. Net assets decreased by 37.36% to 3.55M and EPS decreased from -0.18 to -0.18.